Short answer: In a national survey of US adults, what people paid each month predicted who stopped a GLP-1 as strongly as vomiting did, or more. People paying more than $50 a month out of pocket were 2.7 times as likely to stop. Healio reported the findings from ObesityWeek on November 14.
What the study found
Researchers at the University of Southern California's Schaeffer Institute worked from the Understanding America Study, a national survey panel, instead of insurance claims. Alison Sexton Ward, who presented the work, told Healio why that matters: claims only see people whose insurance pays, and "about four in 10 people using GLP-1s for weight loss paid without insurance."
- 13.7% of participants said they had used a GLP-1, in a survey run from October to December 2025.
- 33.4% of users had stopped by two years: 41% of those taking it for obesity and 22% of those taking it for diabetes.
- Paying $51 or more a month carried a hazard ratio of 2.7 for stopping. Paying $1 to $50 carried 1.8. Vomiting as a side effect carried 2.1.
- Adults using a GLP-1 for obesity lost a mean 19% of their body weight at two years; adults with diabetes lost about 14%.
A hazard ratio of 2.7 means that, at any point in the study, people in that group stopped at about 2.7 times the rate of the comparison group.
What it does and does not show
This is a conference presentation reported by Healio, built on what people said in a survey. It shows that cost and stopping travel together. It does not prove that price alone made anyone stop.
It lines up with other numbers this month. A Milken Institute report covered by Drug Topics cited real-world data in which 47% to 68% of people stop a GLP-1 within a year.
Plan for month six, not month one
"These drugs can produce substantial weight loss that builds over time, but only for people who can afford to stay on them," Sexton Ward told Healio. The price that matters is the one you can keep paying.
- Ask for the monthly price at the dose you expect to end up on, not only the starting dose.
- Ask whether the price you were quoted is a promotion, and when it ends.
- If cost is pushing you to stop, tell your prescriber before you stop. There may be another route, such as a different pharmacy or a different medication.
For more on why people stop ongoing medications, see why people stop taking their medicine.
Where Temi fits
Temi charges for the clinician's review, not for the drug. For a compounded GLP-1 filled by one of our partner pharmacies, you see the medication price and Temi's fee before you pay. The fee is $39 per prescription, or $0 for Temi Care members, and the medication price carries a markup of no more than 15%.




